Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges

X Gao, L Li, X Cai, Q Huang, J Xiao, Y Cheng - Biomaterials, 2021 - Elsevier
A variety of targeted nanoparticles were developed for the diagnosis and therapy of
orthotopic and metastatic bone tumors during the past decade. This critical review will focus …

[HTML][HTML] Bisphosphonate conjugation for bone specific drug targeting

KB Farrell, A Karpeisky, DH Thamm, S Zinnen - Bone reports, 2018 - Elsevier
Bones provide essential functions and are sites of unique biochemistry and specialized
cells, but can also be sites of disease. The treatment of bone disorders and neoplasia has …

Targeted delivery to bone and mineral deposits using bisphosphonate ligands

LE Cole, T Vargo-Gogola, RK Roeder - Advanced drug delivery reviews, 2016 - Elsevier
The high concentration of mineral present in bone and pathological calcifications is unique
compared with all other tissues and thus provides opportunity for targeted delivery of …

Biomedical applications of bisphosphonates

EV Giger, B Castagner, JC Leroux - Journal of Controlled Release, 2013 - Elsevier
Since their discovery over 100years ago, bisphosphonates have been used industrially as
corrosion inhibitors and complexing agents. With the discovery of their pharmacological …

NF-κB as a therapeutic target in inflammatory-associated bone diseases

TH Lin, J Pajarinen, L Lu, A Nabeshima… - Advances in protein …, 2017 - Elsevier
Inflammation is a defensive mechanism for pathogen clearance and maintaining tissue
homeostasis. In the skeletal system, inflammation is closely associated with many bone …

Instrumental methods and techniques for structural and physicochemical characterization of biomaterials and bone tissue: A review

Ž Mitić, A Stolić, S Stojanović, S Najman… - Materials Science and …, 2017 - Elsevier
A review of recent advances in instrumental methods and techniques for structural and
physicochemical characterization of biomaterials and bone tissue is presented in this paper …

A drug carrier for sustained zero-order release of peptide therapeutics

YN Zhao, X Xu, N Wen, R Song, Q Meng, Y Guan… - Scientific reports, 2017 - nature.com
Peptides have great potential as therapeutic agents, however, their clinic applications are
severely hampered by their instability and short circulation half-life. Zero-order release …

Bisphosphonate-modified biomaterials for drug delivery and bone tissue engineering

DA Ossipov - Expert opinion on drug delivery, 2015 - Taylor & Francis
Introduction: Bisphosphonates (BPs) were introduced 45 years ago as anti-osteoporotic
drugs and during the last decade have been utilized as bone-targeting groups in systemic …

Spatiotemporally controlled calcitonin delivery: Long-term and targeted therapy of skeletal diseases

P Yu, Y Liu, J Xie, J Li - Journal of Controlled Release, 2021 - Elsevier
Bone is a connective tissue that support the entire body and protect the internal organs.
However, there are great challenges on curing intractable skeletal diseases such as …

Research progress of bone-targeted drug delivery system on metastatic bone tumors

B Hu, Y Zhang, G Zhang, Z Li, Y Jing, J Yao… - Journal of Controlled …, 2022 - Elsevier
Bone metastases are common in malignant tumors and the effect of conventional treatment
is limited. How to effectively inhibit tumor bone metastasis and deliver the drug to the bone …